Gene · 1828
Papers3,287
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,287
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Acral peeling in Nagashima type palmo-plantar keratosis patients reveals the role of serine protease inhibitor B 7 in keratinocyte adhesion. | Exp Dermatol | 2022 | 34379845 | PubTator, text mining | PubMed |
| Differential Pathomechanisms of Desmoglein 1 Transmembrane Domain Mutations in Skin Disease. | J Invest Dermatol | 2022 | 34352264 | PubTator, text mining | PubMed |
| Proteomic analysis to identify markers for response to neoadjuvant treatment in esophageal and gastroesophageal cancer. | Cancer Rep (Hoboken) | 2022 | 34350714 | PubTator, text mining | PubMed |
| Long non-coding RNAs in diabetic wound healing: Current research and clinical relevance. | Int Wound J | 2022 | 34337861 | PubTator, text mining | PubMed |
| Clinical and serological predictors of relapse in pemphigus: a study of 143 patients. | Clin Exp Dermatol | 2022 | 34288016 | PubTator, text mining | PubMed |
| Human Desmocollin 3‒Specific IgG Antibodies Are Pathogenic in a Humanized HLA Class II Transgenic Mouse Model of Pemphigus. | J Invest Dermatol | 2022 | 34265330 | PubTator, text mining | PubMed |
| Desmoglein-2 expression is an independent predictor of poor prognosis patients with multiple myeloma. | Mol Oncol | 2022 | 34245117 | PubTator, text mining | PubMed |
| Immune system and microbiome in the esophagus: implications for understanding inflammatory diseases. | FEBS J | 2022 | 34213831 | PubTator, text mining | PubMed |
| TGF-β superfamily co-receptors in cancer. | Dev Dyn | 2022 | 33797167 | PubTator, text mining | PubMed |
| ELISA detection of anti-desmoglein 1 and anti-desmoglein 3 and indirect immunofluorescence in oral pemphigus: A retrospective study. | Oral Dis | 2022 | 33721369 | PubTator, text mining | PubMed |
| Efficacy and safety of biosimilar rituximab in the treatment of pemphigus vulgaris: a single center experience of 12 cases. | J Dermatolog Treat | 2022 | 32068447 | PubTator, text mining | PubMed |
| Covid-19 dermatoses: Acral vesicular pattern evolving into bullous pemphigoid. | Skin Health Dis | 2021 | 35664813 | PubTator, text mining | PubMed |
| Human Tissue Kallikreins-Related Peptidases Are Targets for the Treatment of Skin Desquamation Diseases. | Front Med (Lausanne) | 2021 | 35356049 | PubTator, text mining | PubMed |
| Autoantibodies against Desmoglein 1 and 3 in South Tunisian pemphigus. | Tunis Med | 2021 | 35288901 | PubTator, text mining | PubMed |
| A Review Into the Effects of Pamidronic Acid and Zoledronic Acid on the Oral Mucosa in Medication-Related Osteonecrosis of the Jaw. | Front Oral Health | 2021 | 35224540 | PubTator, text mining | PubMed |
| Genetic Profile of Epidermolysis Bullosa Cases in King Abdulaziz Medical City, Riyadh, Saudi Arabia. | Front Genet | 2021 | 35222512 | PubTator, text mining | PubMed |
| Autoimmune Pemphigus: Latest Advances and Emerging Therapies. | Front Mol Biosci | 2021 | 35187073 | PubTator, text mining | PubMed |
| Acute Herpes Simplex Esophagitis in an Immunocompetent Adult with Eosinophilic Esophagitis. | Case Rep Gastroenterol | 2021 | 35110988 | PubTator, text mining | PubMed |
| Selection of Cashmere Fineness Functional Genes by Translatomics. | Front Genet | 2021 | 35096002 | PubTator, text mining | PubMed |
| Case Report: Variety of Target Antigens During 1 Year Follow-Up of a Patient Initially Diagnosed With Bullous Pemphigoid. | Front Immunol | 2021 | 35095927 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1828/papers?page=44